Perrigo (PRGO) Gains from Investment Securities (2012 - 2014)
Perrigo's (PRGO) quarterly Gains from Investment Securities came in at $12.7 million in Q1 2014, up 693.75% year-on-year from $1.6 million in Q1 2013, and up 693.75% on a QoQ basis from $1.6 million in Q1 2013.
Perrigo (PRGO) Gains from Investment Securities (2012 - 2014) Analysis & Trends
Perrigo (PRGO) has 3 years of Gains from Investment Securities data on file, last reported at $12.7 million in Q1 2014.
- On a quarterly basis, Gains from Investment Securities rose 693.75% year-over-year to $12.7 million in Q1 2014; TTM through Jun 2014 was $12.7 million, a N/A change from a year earlier, with the FY2014 full-year figure at $12.7 million, up 170.21% from the prior year.
- Gains from Investment Securities for Q1 2014 stood at $12.7 million, up from $1.6 million in the prior quarter.
- Over the last five years, Gains from Investment Securities for PRGO reached as high as $12.7 million in Q1 2014 and fell as low as $1.6 million in Q1 2013.
- Historically, Gains from Investment Securities has averaged $5.8 million across 3 years, with a median of $3.0 million in 2012.
- On a YoY basis, Gains from Investment Securities climbed as much as 693.75% in 2014 and fell as far as 693.75% in 2014.
- Year by year, Gains from Investment Securities stood at $3.0 million in 2012, then tumbled by 46.67% to $1.6 million in 2013, then jumped by 693.75% to $12.7 million in 2014.
- Per Business Quant data, the three most recent Gains from Investment Securities figures were $12.7 million in Q1 2014, $1.6 million in Q1 2013, and $3.0 million in Q4 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Perrigo | 1.42 Bn | 1.06 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2014 | 12.70 Mn |
| Mar 29, 2014 | 12.70 Mn |
| Mar 30, 2013 | 1.60 Mn |
| Mar 30, 2013 | 1.60 Mn |
| Dec 29, 2012 | 3.00 Mn |
| Dec 29, 2012 | 3.00 Mn |